State of endocrine and immune systems in ovarian cancer patients and their role in antitumor resistance

被引：0
|
作者：
Vorobyova, LI [1 ]
Vinnitskaya, AB [1 ]
Yevtushenko, GV [1 ]
Svintsitsky, VS [1 ]
Mayevskaya, LP [1 ]
Bendyug, GD [1 ]
机构：
[1] MINIST PUBL HLTH UKRAINE,UKRAINIAN RES INST ONCOL & RADIOL,UA-252022 KIEV,UKRAINE
来源：
EXPERIMENTAL ONCOLOGY | 1997年 / 19卷 / 03期
关键词：
ovarian cancer; antitumor resistance; homeostasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The results of investigation of some hormonal homeostatic indices and immunity of patients with disseminated ovarian cancer are given. Initial relative hyperestrogenization in these patients is detected. Effective complex treatment results in the improvement and normalization of hormonal homeostatic indices (increase of FSH, progesterone, essential decrease of prolactin). Data of the immunologic study testify to a significant inhibition of the immune system in ovarian cancer patients in administration of platidiam, these changes are less expressed in administration of polyplatillen.
引用
收藏
页码：242 / 245
页数：4
相关论文
共 50 条
  • [1] The role of macrophages in antitumor defense of patients with ovarian cancer
    Zavadova, E
    Loercher, A
    Verstovsek, S
    Verschraegen, CE
    Micksche, M
    Freedman, RS
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (01) : 135 - +
  • [2] Endocrine role in ovarian cancer
    Rao, BR
    Slotman, BJ
    ENDOCRINE-RELATED CANCER, 1996, 3 (04) : 309 - 326
  • [3] Endocrine and immune responses to resistance training in prostate cancer patients
    D A Galvão
    K Nosaka
    D R Taaffe
    J Peake
    N Spry
    K Suzuki
    K Yamaya
    M R McGuigan
    L J Kristjanson
    R U Newton
    Prostate Cancer and Prostatic Diseases, 2008, 11 : 160 - 165
  • [4] Endocrine and immune responses to resistance training in prostate cancer patients
    Galvao, D. A.
    Nosaka, K.
    Taaffe, D. R.
    Peake, J.
    Spry, N.
    Suzuki, K.
    Yamaya, K.
    McGuigan, M. R.
    Kristjanson, L. J.
    Newton, R. U.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2008, 11 (02) : 160 - 165
  • [5] Dissecting antitumor immune response in ovarian cancer
    Coukos, George
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [6] ROLE OF ENDOCRINE THERAPY IN OVARIAN-CANCER
    EMONS, G
    ORTMANN, O
    SCHULZ, KD
    GYNAKOLOGE, 1993, 26 (02): : 123 - &
  • [7] The role of the immune response in ovarian cancer
    Clarke, Blaise
    Kalloger, Steve
    Turbin, Dmtry
    Santos, Jennifer
    Swenerton, Ken
    Huntsman, David
    Gilks, Cyril
    Moravan, Veronica
    MODERN PATHOLOGY, 2006, 19 : 93 - 93
  • [8] Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
    Gopinathan, Ganga
    Berlato, Chiara
    Lakhani, Anissa
    Szabova, Ludmila
    Pegrum, Colin
    Pedrosa, Ana-Rita
    Laforets, Florian
    Maniati, Eleni
    Balkwill, Frances R.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (06) : 1030 - 1043
  • [9] Role of cancer stem cells and microRNA in resistance to chemotherapy in patients with ovarian cancer
    Markowska, A.
    Sajdak, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 181 - 183
  • [10] The role of hormonal factors and endocrine therapy in ovarian cancer
    Serkies, Krystyna
    Sinacki, Marcin
    Jassem, Jacek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (01): : 14 - 19
12345